Masa Onozaki

Masa Onozaki serves as President & CEO at Nobelpharma America, LLC. Nobelpharma America, LLC operates in the pharmaceuticals sector with approximately 21.0 employees. The company is headquartered in Tokyo, Tokyo.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 440 executive contacts are available in Tokyo.
• • Our database includes 201,468 c suite-level executives.

Route 53 Outlook WordPress.org Apache reCAPTCHA Mobile Friendly Google Tag Manager Remote

pharmaceutical manufacturing medical devices rare diseases treatment options research & development fda approvals critical care neglected diseases patient care first-in-class drugs best-in-class drugs global market healthcare providers small patient populations therapy development patient first approach disease education clinical trials essential medicines drug delivery innovative therapies collaboration patient needs healthcare access community contribution medical innovation therapeutic solutions drug manufacturing clinical management advanced medicine regulatory compliance socio-economic impact market entry drug safety treatment accessibility production efficiency patient engagement therapeutic development investigational drugs medical ethics patient outcomes healthcare solutions disease management patient support employment philosophy employee development business ethics corporate responsibility pharmaceuticals medical hospital & health care health care health wellness & fitness

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Masa Onozaki in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Nobelpharma America, LLC.

Masa Onozaki's Position in the MessageCEO Database

• •Masa Onozaki is 1 of 1 verified executive contact we track at Nobelpharma America, LLC.
• •1,240 verified executive contacts in pharmaceuticals are in the MessageCEO database.
• •437 verified executive contacts in Tokyo are in the database.
• •11 verified contacts work at pharmaceuticals companies in the 21.0 employee range (same size as Nobelpharma America, LLC).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Masa Onozaki directly?

Masa Onozaki's verified email address is available to MessageCEO Pro subscribers. They currently serve as President & CEO at Nobelpharma America, LLC. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Masa Onozaki work for?

Masa Onozaki is President & CEO at Nobelpharma America, LLC, a company in the pharmaceuticals sector with 21.0 employees. The company is based in Tokyo, Tokyo.

Can I pitch or sell to Masa Onozaki?

As President & CEO at Nobelpharma America, LLC, Masa Onozaki is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Masa Onozaki directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Masa Onozaki in?

Masa Onozaki works in the pharmaceuticals industry as President & CEO at Nobelpharma America, LLC. MessageCEO provides verified contact information for executives across all major industries.

Is Masa Onozaki's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Masa Onozaki's profile is kept up-to-date with the latest available information.

Last updated: July 26, 2026